Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens-Reference-Cited by-同舟云学术

Optimal HIV Postexposure Prophylaxis Regimen Completion With Single Tablet Daily Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine Compared With More Frequent Dosing Regimens

Published:2017-08-15 Issue:5 Volume:75 Page:535-539
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Mayer Kenneth H.,Jones Daniel,Oldenburg Catherine,Jain Sachin,Gelman Marcy,Zaslow Shayne,Grasso Chris,Mimiaga Matthew J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference38 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med.,2010

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med.,2012

3. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med.,2012

4. Preexposure prophylaxis for HIV infection among African women;Van Damme;N Engl J Med.,2012

5. World health organization postexposure prophylaxis guideline development group. World health organization guidelines on postexposure prophylaxis for HIV: recommendations for a public health approach;Ford;Clin Infect Dis.,2015

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study;BMC Infectious Diseases;2024-06-06

2. Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions;The Lancet HIV;2023-12

3. Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV-1: What is the Hidden Potential of This Emerging Treatment?;HIV/AIDS - Research and Palliative Care;2023-11

4. Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP);Open Forum Infectious Diseases;2023-07-19

5. An open-label evaluation of safety and tolerability of coformulated bictegravir/emtricitabine/tenofovir alafenamide for post-exposure prophylaxis following potential exposure to human immunodeficiency virus-1;Chinese Medical Journal;2022-12-28